170 related articles for article (PubMed ID: 21771578)
41. A High-Throughput Assay for Developing Inhibitors of PhoP, a Virulence Factor of Mycobacterium tuberculosis.
Wang L; Xu M; Southall N; Zheng W; Wang S
Comb Chem High Throughput Screen; 2016; 19(10):855-864. PubMed ID: 27748178
[TBL] [Abstract][Full Text] [Related]
42. Analyzing lipid metabolism: activation and beta-oxidation of fatty acids.
Wheeler PR
Methods Mol Biol; 2009; 465():47-59. PubMed ID: 20560058
[TBL] [Abstract][Full Text] [Related]
43. High-throughput fluorescence polarization assay to identify inhibitors of Cbl(TKB)-protein tyrosine kinase interactions.
Kumar EA; Charvet CD; Lokesh GL; Natarajan A
Anal Biochem; 2011 Apr; 411(2):254-60. PubMed ID: 21129358
[TBL] [Abstract][Full Text] [Related]
44. Molecular dissection of the role of two methyltransferases in the biosynthesis of phenolglycolipids and phthiocerol dimycoserosate in the Mycobacterium tuberculosis complex.
Pérez E; Constant P; Laval F; Lemassu A; Lanéelle MA; Daffé M; Guilhot C
J Biol Chem; 2004 Oct; 279(41):42584-92. PubMed ID: 15292265
[TBL] [Abstract][Full Text] [Related]
45. High-throughput screening fluorescence polarization assay for tumor-specific Hsp90.
Du Y; Moulick K; Rodina A; Aguirre J; Felts S; Dingledine R; Fu H; Chiosis G
J Biomol Screen; 2007 Oct; 12(7):915-24. PubMed ID: 17942784
[TBL] [Abstract][Full Text] [Related]
46. High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases.
Loomans EE; van Doornmalen AM; Wat JW; Zaman GJ
Assay Drug Dev Technol; 2003 Jun; 1(3):445-53. PubMed ID: 15090181
[TBL] [Abstract][Full Text] [Related]
47. [Identification of ligands for human LOX-1 through fluorescence polarization-based high throughput screening].
Zhang TT; Huang ZT; Dai Y; Liu AL; Zhu P; Du GH
Yao Xue Xue Bao; 2005 Sep; 40(9):792-5. PubMed ID: 16342678
[TBL] [Abstract][Full Text] [Related]
48. What is the current value of fluorescence polarization assays in small molecule screening?
Uri A; Nonga OE
Expert Opin Drug Discov; 2020 Feb; 15(2):131-133. PubMed ID: 31833421
[No Abstract] [Full Text] [Related]
49. Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitors.
McWhirter C; Tonge M; Plant H; Hardern I; Nissink W; Durant ST
J Biomol Screen; 2013 Jun; 18(5):567-75. PubMed ID: 23427045
[TBL] [Abstract][Full Text] [Related]
50. Ligand Discovery: High-Throughput Binding: Fluorescence Polarization (Anisotropy).
Holdgate GA; Hemsley PE
Methods Mol Biol; 2021; 2263():231-246. PubMed ID: 33877601
[TBL] [Abstract][Full Text] [Related]
51. Long-chain multiple methyl-branched fatty acid-containing lipids of Mycobacterium tuberculosis: biosynthesis, transport, regulation and biological activities.
Jackson M; Stadthagen G; Gicquel B
Tuberculosis (Edinb); 2007 Mar; 87(2):78-86. PubMed ID: 17030019
[TBL] [Abstract][Full Text] [Related]
52. Insights into Substrate Modification by Dehydratases from Type I Polyketide Synthases.
Faille A; Gavalda S; Slama N; Lherbet C; Maveyraud L; Guillet V; Laval F; Quémard A; Mourey L; Pedelacq JD
J Mol Biol; 2017 May; 429(10):1554-1569. PubMed ID: 28377293
[TBL] [Abstract][Full Text] [Related]
53. Single-nucleotide polymorphism in the fadD28 gene as a genetic marker for East Asia Lineage Mycobacterium tuberculosis.
Chuang PC; Chen HY; Jou R
J Clin Microbiol; 2010 Nov; 48(11):4245-7. PubMed ID: 20826639
[TBL] [Abstract][Full Text] [Related]
54. Development of a pterin-based fluorescent probe for screening dihydropteroate synthase.
Zhao Y; Hammoudeh D; Lin W; Das S; Yun MK; Li Z; Griffith E; Chen T; White SW; Lee RE
Bioconjug Chem; 2011 Oct; 22(10):2110-7. PubMed ID: 21916405
[TBL] [Abstract][Full Text] [Related]
55. A high-throughput fluorescence polarization anisotropy assay for the 70N domain of replication protein A.
Souza-Fagundes EM; Frank AO; Feldkamp MD; Dorset DC; Chazin WJ; Rossanese OW; Olejniczak ET; Fesik SW
Anal Biochem; 2012 Feb; 421(2):742-9. PubMed ID: 22197419
[TBL] [Abstract][Full Text] [Related]
56. A novel non-radioactive primase-pyrophosphatase activity assay and its application to the discovery of inhibitors of Mycobacterium tuberculosis primase DnaG.
Biswas T; Resto-Roldán E; Sawyer SK; Artsimovitch I; Tsodikov OV
Nucleic Acids Res; 2013 Feb; 41(4):e56. PubMed ID: 23267008
[TBL] [Abstract][Full Text] [Related]
57. Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization.
Nikolovska-Coleska Z; Wang R; Fang X; Pan H; Tomita Y; Li P; Roller PP; Krajewski K; Saito NG; Stuckey JA; Wang S
Anal Biochem; 2004 Sep; 332(2):261-73. PubMed ID: 15325294
[TBL] [Abstract][Full Text] [Related]
58. A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis.
Gold B; Warrier T; Nathan C
Methods Mol Biol; 2015; 1285():293-315. PubMed ID: 25779324
[TBL] [Abstract][Full Text] [Related]
59. Identification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR Validation.
Wang Z; Bhattacharya A; Ivanov DN
PLoS One; 2015; 10(9):e0138780. PubMed ID: 26390015
[TBL] [Abstract][Full Text] [Related]
60. Lineage-specific differences in lipid metabolism and its impact on clinical strains of Mycobacterium tuberculosis.
Moopanar K; Mvubu NE
Microb Pathog; 2020 Sep; 146():104250. PubMed ID: 32407863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
